Patent Abstract:
A lancing device integrated with a sensing strip and method of making and using the same are provided. A lance and analyte sensing strip are combined in a single, preferably disposable, device. In a preferred embodiment, a slot is provided in a support member so the lance can be engaged by a lance driver and driven into the skin producing a bodily fluid sample from a wound. The sensing area of the sensing strip is adjacent to the wound location reducing dexterity requirements for patients.

Full Description:
[0001]     This application is a divisional of U.S. patent application Ser. No. 10/259,798, filed Sep. 30, 2002. 
     
    
     FIELD OF THE INVENTION  
       [0002]     The present invention relates to bodily fluid collection and testing devices. In particular, the present invention relates to a device integrating a lancet and bodily fluid chemistry sensor to provide a single, preferably disposable unit.  
       BACKGROUND OF THE INVENTION  
       [0003]     Conventional self-monitoring of blood glucose requires the patient to first load a lancet into a lancer and a separate test strip into a blood glucose meter. The lancer and, lancet are then used to prick the finger, and a small drop of blood is squeezed to the surface. Finally, the sample port on the strip is brought into contact with the blood, and the sample is transported to the reaction zone on the strip via capillary action. This can be a labor-intensive, uncomfortable process that requires multiple devices and disposables. Further, patients must repeat this process several times a day in order to manage their disease properly.  
         [0004]     Self monitoring of blood glucose is further complicated by the use of small-volume strips when the user is required to manipulate sub-microliter samples (&lt;1 μl). It may be difficult for a person with diabetes to see and align a test strip with such a small sample, particularly for patients who are elderly or who otherwise do not have the dexterity of healthy individuals.  
         [0005]     U.S. Pat. No. 5,971,941, to Simons et al., discloses a lancet and test strip integrated into a disposable cartridge. U.S. Pat. No. 6,143,164, to Heller et al., discloses a small volume in-vitro analyte sensor. U.S. Patent Application Publication No. US 2002/0130042 to Moerman et al. appears to discloses an apparatus for detection and quantization of an electrochemically detectable analyte, such as glucose, in blood or interstitial fluid, having a meter, a lancet and an electrochemical sensor. In one embodiment, an absorptive member is disposed to take up a sample of fluid from the pierced skin of the user without movement of the apparatus.  
       SUMMARY OF THE INVENTION  
       [0006]     The present invention as exemplified in the embodiments disclosed herein, relates to a device that can be used to obtain a sample of bodily fluid for analyte measurement, having an integrated lancet and detection chemistry (sensor) in a single disposable unit. The unit is preferably sterilizable and compatible with cartridge dispensers. A device according to an embodiment of the invention first allows a droplet of bodily fluid to form on the skin, then ensures automatic alignment of the sample port to the bodily fluid droplet for transfer of the sample to the sample port and sensor surface. An embodiment of the invention uses wicking of the sample to improve sample transport and to remove bodily fluid from wound site.  
         [0007]     Another embodiment of the invention is a device for obtaining a sample of bodily fluid by first piercing the skin so that the resulting bodily fluid directly enters a sensor, such as an electrochemical glucose sensor. The device integrates a lancing mechanism and a sensing mechanism, and is preferably adapted to be used with a glucose meter. Thus, a movable lancet or needle is constructed so that it mates with a glucose test strip. The combination device is positioned next to a user&#39;s skin so that the wound created by the lancet or needle is designed to be located a precise distance from the operating surface of the sensing strip. The drop of bodily fluid formed by the lancing action impinges on the sensing strip when it reaches a critical size. In one embodiment, the strip employs a capillary tube or a wick to carry the bodily fluid to the sensing surface. The distance from the skin surface to the sensing surface is preferably less than about 2 mm. 
     
    
     BRIEF DESCRIPTION OF THE DRAWINGS  
       [0008]     The invention will be more readily understood with reference to the embodiments illustrated in the attached drawing figures, in which:  
         [0009]      FIGS. 1   a  to  1   d  illustrate a first embodiment of the present invention employing a flat support member fitted with guides for a lancet and test strip;  
         [0010]      FIG. 2   a  is a perspective view of a cartridge containing lance and test strip assemblies according to an embodiment of the present invention;  
         [0011]      FIG. 2   b  is a cross-sectional side view of the cartridge of  FIG. 2   a;    
         [0012]      FIG. 2   c  is a bottom view of the cartridge of  FIGS. 2   a  and  2   b;    
         [0013]      FIG. 3  illustrates a second embodiment of the present invention employing a flat support member with cantilever arms so that the direction of lancing can be offset from the plane of the strip; and  
         [0014]      FIGS. 4   a  and  4   b  illustrate a third embodiment of the present invention wherein the test strip is brought into position for contact with the bodily fluid sample after the lancing action;  
         [0015]      FIG. 5  illustrates a device according to the invention in use with a lancing device;  
         [0016]      FIGS. 6   a - 6   c  are cross sectional views of an embodiment of the present invention;  
         [0017]      FIG. 7  is a cross sectional view of a lance and test strip assembly inserted into a lancing device according to another embodiment of the present invention;  
         [0018]      FIG. 8   a  is a cross sectional view of a lance and test strip assembly inserted into a lancing device according to another embodiment of the present invention; and  
         [0019]      FIG. 8   b  illustrates a lancet with an integrally formed retention spring. 
     
    
       [0020]     In the drawing figures, it will be understood that like numerals refer to like features and structures.  
       DETAILED DESCRIPTION OF THE INVENTION  
       [0021]     The preferred embodiments of the invention will now be described with reference to the attached drawing figures.  FIG. 1   a  illustrates a first embodiment of the present invention. The device  100  comprises a sensing strip  102 , a rigid plastic strip similar to currently marketed glucose strips. Preferably, one face of the strip holds sensing components  104 . In the embodiment illustrated in  FIG. 1   a , the sensing strip  102  is incorporated into a flat support member  108 . The support member  108  has a slot  110  incorporated therein to allow access to a lancet  106  within. The lancet  106  is adapted to be engaged by a lancing device (not shown). The lancet  106  is preferably manufactured with a hole  107  to be engaged by the lancing device. Of course, the lancet  107  could also be manufactured with a detent, or any other similar structure adapted to be engaged by a lancing device and remain with in the scope of the invention. The hole is described herein as corresponding to the currently preferred embodiment of the invention. During use, the lancet  106  is driven into the skin and then retracted so that the resulting wound is free to release bodily fluid or bleed.  
         [0022]     Strip  102  is preferably inserted into support member  108  during manufacturing. However, in an alternate embodiment of the invention, support member  108  is manufactured to accept a sensing strip  102 , but the sensing strip remains separate until the device  100  is prepared for use. In this embodiment, the strip  102  is preferably kept sterile and inserted into the support member  108  before use. The strip  102  is preferably fixedly attached to support member  108  when installed.  
         [0023]     The sensing components  104  preferably employ electrochemical means for sensing an analyte, such as glucose, but other means of sensing analytes which are known in the art are to be considered within the scope of the present invention. In the case of an electrochemical sensor, the chemistry is arranged to make contact with conductive strips (not shown) such that in the presence of bodily fluid a circuit is completed. The term “bodily fluid” used herein will be understood to include blood, interstitial fluid, and combinations thereof. The conductive strips in turn provide electrical contact with the meter portion of the device  112  as shown in  FIG. 1   b . The electronics of the metering device  112  are preferably adapted to provide a voltage across the sensing area  104  and measure current through the circuit created in the presence of a bodily fluid sample.  
         [0024]      FIG. 1   c  illustrates the device  100  in a first configuration, with the lancet  106  stored within the cartridge  108 , such that the lancet is not exposed outside the support member  108  to pose an accidental prick hazard.  FIG. 1   d  illustrates the device  100  in a second configuration, with the lancet  106  exposed. A combination lancet driver and glucose meter (not shown) engages the lancet  106  through slot  110 , and drives the lancet  106  from the first position to the exposed position to cause a wound, and then withdraw the lancet  106  from the wound to facilitate bleeding, and the subsequent formation of a bodily fluid droplet.  
         [0025]     Glucose sensing strips typically employ a capillary flow to transport bodily fluid to the sensing chemistry. In the current device, a capillary flow is also preferably employed, and the strip  102  is initially positioned within the support member  108  such that the capillary flow tube contacts the droplet of bodily fluid generated by the lancet  106 . The bodily fluid volume needed is preferably less than 0.5 μl. Adequate volume can be obtained from the fingertip or even off the fingertip, such as on the inner or outer forearm, using relatively pain-free lancets. Bodily fluid flow from a small lancet or needle can be enhanced by a properly designed supporting structure. Typically, an annular structure is brought to bear against the skin with an opening sized to spread the skin with a certain tension such that the wound will be held open after penetration. Bodily fluid is also pushed to the wound by the pressure of holding the device to the skin. In the preferred embodiment of the present invention, the opening and the sensing strip are appropriately positioned relative to each other such that the formation of the bodily fluid drop is optimally positioned for use by the sensing strip.  
         [0026]     The strip  102  also preferably contains a wicking device, such as cellulose or nylon fibers, such that bodily fluid emerging from the skin immediately contacts the wick and is transported to the sensing surfaces  104 . Such a wick also has the function of removing most bodily fluid from the skin surface, leaving a clean wound site requiring less subsequent activity by the user of the device.  
         [0027]     A device according to the embodiment of  FIGS. 1   a - 1   d  simplifies the monitoring process by combining a lancet  106  and a test strip  102  into a single disposable unit, and by combining the lancer and meter into a single device. During the monitoring process, the sample port of the strip becomes automatically aligned with the bodily fluid sample, so there is minimal patient intervention required. The integration of lancing and testing into a single unit greatly simplifies the glucose monitoring process.  
         [0028]     The device illustrated in  FIGS. 1   a - 1   d  improves upon the prior art by requiring fewer actions by the user. The device also advantageously utilizes small volumes of bodily fluid which allow off-finger testing. Furthermore, the device is advantageous in that it contains the bodily fluid sample in a disposable container, and requires only one part as opposed to two. The device also allows for sterilization of the lancet  106  during manufacture without adversely affecting the sensing portion  104  of the device. Examples of sterilization techniques which can adversely affect an electrochemical test strip include electron beam radiation and gamma radiation.  
         [0029]     Using prior art devices, a user typically must first pierce his or her skin with a lancing device, then bring to bear a separate electrochemical sensor contained in a separate or the same housing. With the current device, the lancing and sampling activities are performed using one device and require fewer user actions. Advantageously, there is no requirement for the user to reposition the sensing chemistry over the bodily fluid droplet.  
         [0030]     Existing glucose monitors utilize a volume of blood which has previously been brought to the skin surface after application of a separate lance. The lance and sensing strip are typically contained in separate housings, and may also be contained in one housing, but are always separate parts. In the device of  FIGS. 1   a - 1   d , the skin piercing and the sensing components are contained in one complete and disposable cartridge. The device  100  is preferably sized to contain most or all of the bodily fluid produced by the lancing action, leaving less residue on the skin or device for the user to deal with. The blood is thereby contained in a disposable and safely handled item.  
         [0031]     The device of  FIGS. 1   a - 1   d  allows independent fabrication of the sensing component and the lancing component up to a certain point in the manufacturing process where they are mated. This allows for sterilization of the lancing component without adversely affecting the sensing component (e.g. the enzymes used for electrochemical sensing of glucose). In certain embodiments of the device, the lancet may be encased in a plastic cap to maintain sterility. The cap is removed by the user or by the lancing device prior to use.  
         [0032]     In a preferred embodiment of the invention, a plurality of the devices shown in  FIGS. 1   a - 1   d  are packaged as part of a cartridge which is adapted to be inserted into a lancer or combination lancer and meter. The cartridge design is variable depending on the geometry of the lance and testing strip assembly. Stacked flat assemblies as shown in  FIGS. 1    a - 1   d  are preferable. However, different arrangements, such as spokes on a wheel, or short tubes stacked within a longer tube, should be considered within the scope of the invention.  
         [0033]     In the presently contemplated best mode of the invention, a plurality of the devices  100  illustrated in  FIGS. 1   a - 1   d  are packaged in a cartridge  114  as illustrated in  FIGS. 2   a - 2   c , ready for insertion into a handheld, portable glucose meter. As shown in  FIG. 2   a , the cartridge  114  has an opening  116  adapted to allow access to the sensing. surface  104  of the bottom-most assembly  101  in the stack. Opening  116  is also used to eject the bottom-most assembly  101  after use. Alternatively, opening  116  can be used to eject the bottom-most assembly  101  prior to use in a portable glucose meter.  
         [0034]     The lance and test strip assemblies  100  are preferably oriented within cartridge  114  such that slot  110  is aligned with a slot  118  in the bottom of cartridge  114  as shown in  FIG. 2   c . Also, springs  120  and plate  122  keep the stack of assemblies  100  positioned at the bottom of the cartridge such that the bottom-most assembly  101  is aligned with opening  116  and slot  118 . In this manner, the portable glucose meter (not shown) has access to, and can drive the lance  106  within the bottom-most assembly  101 . Used devices are retained in a sealed portion of the meter for disposal, or are automatically ejected from the meter without requiring handling by the user. Existing technology for the electrochemical detection of glucose or other analytes can be utilized for the sensing strip portion of the device.  
         [0035]      FIG. 3  illustrates an alternate embodiment of the present invention that advantageously allows the angle φ between the direction of movement of the lancet and the plane of the sensing surfaces to be variable. The device  200  comprises a generally flat strip  202  having a sensing area  204 . Electrical conductors  205  are connected between the sensing area  204  and electrodes  207  for connection to the metering device  212 . Flat strip  204  serves structurally as a primary support member for cantilever members  208  and lancet support member  210 . Lancet  206  is attached to lancet support member  210 . Prior to use, the device  200  is preferably configured in a flat manner to allow several devices to be packaged in a cartridge  114  as inserts to a portable meter device. Bendable arms  208  and  210  are preferably manipulated once the strip is engaged in the lancer or meter. This design allows for optimization of the angle φ between the two parts of the device during use.  
         [0036]     A stack of assemblies  200  can be advantageously packaged in a cartridge  114  while in their flat configuration. The bottom-most assembly is partially or fully ejected from the cartridge  114  through opening  116  in order to manipulate the device into the angled orientation shown in  FIG. 3 .  
         [0037]     The lancet or needle can be sized according to the amount of bodily fluid desired. Preferably the bodily fluid volume needed is less than 0.5 μl. The penetrating portion of the lancet can be constructed from a flat or round blank. The transport of bodily fluid to the sensing surfaces is accomplished by any of a variety of means, including a capillary flow tube or a wick, or even a vacuum. The device can be used in conjunction with a handheld, portable lancer or meter, or can be made to function in as part of a larger test unit.  
         [0038]      FIGS. 4   a  and  4   b  illustrate a device  300  according to a third embodiment of the present invention. In this embodiment, the device  300  automatically moves the sensing strip  304  into position after the lancet  306  is withdrawn from the skin. A lateral displacement of one to two millimeters is created by pressing a push button  312  on the device support structure. The push button  312  is used to trigger the lancet  306  when pressed, and also to displace the strip  304  when released.  
         [0039]      FIG. 4   a  illustrates the device  300  after the push button  312  has been pressed, releasing the lancet  306  into the skin  313 . As push button  312  is released, lancet  306  has been withdrawn from the skin, and spring  314  causes sensing strip  304  to be displaced to the location of the wound  316 , as shown in  FIG. 3   b . A wick  318  is preferably included to aid bodily fluid flow to the sensing area by capillary action. Alternatively, an electromagnet or other automatic mechanism is be used to laterally or vertically displace the strip once a set period after lancing has elapsed.  
         [0040]     Of course the embodiment shown in  FIGS. 4   a  and  4   b  can easily be adapted for use in the cartridge  114  of  FIGS. 2   a - 2   c . In the cartridge configuration, spring  314  and push button  312  preferably act on the cartridge  114 , causing test strip  102  and in particular sensing components  104  on the bottom-most assembly within the cartridge to come into contact with a bodily fluid droplet that has formed on the surface of the skin after a predetermined about of time has elapsed to allow the droplet to form and achieve the desired volume.  
         [0041]     The lancer or meter which uses any of the embodiments described herein can also embody design features that make sampling more reliable. An important aspect of bodily fluid sampling is to ensure proper pressure of the lancer housing on the skin. This ensures that the skin surface is positioned correctly relative to the axis of travel of the lancet and the orientation of the strip. This pressure also ensures reliable penetration depth of the lancet, which in turn ensures proper bodily fluid flow. Finally, this pressure also stretches the skin, keeping the wound open to ease bodily fluid flow. A pressure sensor on the lancer housing can be used to indicate to the user that the proper pressure has been achieved, and can also be part of an interlock system preventing premature lancing.  
         [0042]     The lance and test strip can be positioned within the portable meter device in such a way that the distance between the piercing&#39;site and the sample port of the test strip are precisely spaced. Such a spacing allows adequate bodily fluid volume to build up on the skin before encountering the sample port.  
         [0043]     Another advantage of the embodiments described above is that the lance and sensing strip portions of the device can be manufactured independently to a great degree. Thus, sterilization of the lancing tip can be achieved without concern for detrimental effects on glucose sensing chemistry, which can be manufactured with aseptic techniques. The two functioning components of the device are preferably “snap fit” together just prior to packaging to maintain the desired level of sterility.  
         [0044]     Proper and precise alignment of the two parts may also be ensured by the lancer or meter. Thus, although each separate part may require precise fabrication, assembly of parts during manufacture does not require precise alignment. For example, in the design shown in  FIG. 1   a , the lance  106 , test strip  102 , and support member  108  can fit together loosely, and insertion of the device in the lancer or meter provides a precise structural support for each part.  
         [0045]     It has been observed that it is much easier to get a bodily fluid sample to flow into a capillary tube if the drop is fully formed. If there is a break in the flow of bodily fluid in a capillary, the capillary action stops. It is also advantageous to create only one wave of bodily fluid flow over the sensing area. Electrochemical sensing relies on a constant delivery rate of glucose to the sensing components (e.g., enzymes). An interrupted flow of bodily fluid can create variable glucose delivery rates to the sensor, causing errors in measurement. Allowing sufficient bodily fluid to form within a drop on the skin before it is carried to the sensing surface (by, for example, a capillary or wick) reduces this source of errors. Moving the sensor strip onto the drop of bodily fluid as illustrated in  FIGS. 4   a  and  4   b  ensures that variations. in skin tension and height, which might cause variations in bodily fluid drop placement relative to the strip, do not cause premature entry of bodily fluid into the sensing area.  
         [0046]     Another embodiment of a device  100  according to the present invention is shown in  FIG. 5 . The device  100  can be inserted into a combined bodily fluid meter and lancer  500 . Combined meter and lancer  500  has an opening  502  adapted to accept the device  100 . It also has a driver  504  that is adapted to receive and drive lance  106 , and a strip receiver  506  that is adapted to receive the test strip  102 . When the device  100  is inserted into opening  502 , lance  106  becomes fixedly engaged in driver  504 , and test strip  102  becomes fixedly engaged in strip receiver  506 . In the illustrated embodiment, test strip  102  preferably has electrical contacts on the exposed proximal portion of test strip  102 , which are arranged to make contact with corresponding electrical contacts in the strip receiver  506 . Thus, when the device  100  is inserted into the combined meter and lancer  500 , the strip  102  forms an electrical circuit with the meter.  
         [0047]     Driver  504  is connected to driving means (not shown) that are adapted to cock the lance, drive it into the skin of a user, and withdraw the lance so that bodily fluid is free to flow from the small wound created by the lance.  
         [0048]      FIGS. 6   a - 6   c  are cross sections of a device  600  according to another embodiment of the present invention. Lance  106  includes a cap  602  which protects the point of the lance prior to use. The cap  602  is preferably insert molded around the lance to maintain the sterility of the lance. The cap  602  is also preferably frangible so that it breaks away from the lance easily upon use. Device  600  includes a housing  108  that is adapted to contain the lance  106  and test strip  102 . Housing  108  also includes a channel member  604  that creates separate channels for storing the lance and through which the lance travels when in use, as will be described in greater detail below. Housing  108  also preferably includes cap retaining slot  606  that holds the cap in a fixed location once the lance  106  and housing  108  are assembled. The proximal end of the lance  106  is allowed to protrude from the housing  108  to facilitate the lance  106  being engaged by the driver (not shown) in the combined meter and lancer  500 .  
         [0049]     When the device is cocked, lance  106  is first drawn in a proximal direction, causing frangible cap  602  to break away, exposing the lance point, as shown in  FIG. 6   b . As shown in  FIG. 6   c , housing  108  preferably contains a biasing means  608  such as a spring to force the lance into channel  610 . Thus when lance  106  is driven into the skin of the user, it travels through channel  610 .  
         [0050]     It will be appreciated that many embodiments and variations are possible within the scope of the invention.  FIG. 7  illustrates a cross-section of another embodiment of the invention. In this embodiment, the lance  106  is embedded in plastic  700  to remain sterile. The combined meter and lancer has a plunger  702  that attaches to the lance  106 . When the plunger  702  drives the lance  106  into the skin of the user, plastic  700  is retained against ridge  704 , so that lance  106  protrudes from plastic  700 . In this manner, lance  106  remains sterile until it is actually used. A spring  706  is also preferably provided to help withdraw the lance  106  back into the device.  
         [0051]      FIG. 8   a  illustrates an embodiment similar to  FIG. 7 , but wherein the retention spring  706  is incorporated into the lance  106 .  FIG. 8   b  illustrates a perspective view of the lance  106  of  FIG. 8   a  having an incorporated retention spring  706 .  
         [0052]     While the invention herein disclosed has been described by means of specific embodiments and applications thereof, numerous modifications and variations can be made thereto by those skilled in the art without departing from the scope of the invention as set forth in the claims.

Technology Classification (CPC): 0